Search
Astrana Health Inc
ASTHAdd to Watchlist
34.360USD
+0.060+0.17%
Close 09-18 16:00（ET）
1.69BMarket Cap
55.67P/E TTM
Astrana Health Inc (ASTH) Stock Price Target & Forecast
Analyst Rating
Based on 11 analysts giving stock ratings to Astrana Health Inc in the past month.
Buy
5 Strong Buy
5 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
50.800USD+32.46%
ASTH Analyst Recommendation Trends
In the current month, ASTH has received 5 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. ASTH average Analyst price target in the last month is 50.800.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
3
1
1
2
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11
11
11
11
11
11
11
10
ASTH Analyst Rating for Peer Comparison
Updated: Sep 18, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
CVS Health Corp
CVS
7
18
4
0
0
29
HCA Healthcare Inc
HCA
5
9
11
1
0
26
Teladoc Health Inc
TDOC
2
4
19
0
0
25
Natera Inc
NTRA
10
12
3
0
0
25
Tenet Healthcare Corp
THC
5
15
3
0
0
23
Universal Health Services Inc
UHS
2
4
15
1
0
22
Labcorp Holdings Inc
LH
7
9
4
0
0
20
Quest Diagnostics Inc
DGX
5
5
9
0
0
19
Privia Health Group Inc
PRVA
6
12
1
0
0
19
Brightspring Health Services Inc
BTSG
7
12
0
0
0
19
Financial Forecasting
Based on analysts' estimates, ASTH EPS is projected to reach 0.461 in FY2026Q3, following reported EPS of 0.402 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
0.11
0.30
0.34
0.46
0.27
Actual
0.12
0.30
0.40
--
--
Surprise
+14.83%
-1.14%
+19.61%
--
--
FAQs
What is Astrana Health Inc's expected revenue for the next quarter?
Astrana Health Inc's expected revenue is 1.02B.
What is Astrana Health Inc's price target?
Analysts forecast that Astrana Health Inc's price target is USD 50.80, with the highest forecast at USD 65.00 and the lowest forecast at USD 41.00.
How have Astrana Health IncASTH's recent earnings per share performed?
The market expectation was USD 0.40, while Astrana Health IncASTH's earnings per share (EPS) for the previous quarter was USD 0.30. EPS for the next quarter is expected at USD 0.46.
What is the analyst rating for Astrana Health Inc?
Based on the ratings of Astrana Health Inc's stock from 11 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.